McKesson
MCK
#179
Rank
NZ$198.08 B
Marketcap
NZ$1,605
Share price
-0.14%
Change (1 day)
42.97%
Change (1 year)
McKesson Corporation is an American company distributing pharmaceuticals and providing health information technology, medical supplies, and care management tools.

EPS for McKesson (MCK)

EPS in 2025 (TTM): NZ$60.12

According to McKesson's latest financial reports the company's current EPS (TTM) is NZ$59.50. an increase over its 2024 EPS that were of NZ$37.42.

EPS history for McKesson from 2014 to 2025

Annual EPS

Year EPS Change
2025NZ$59.2458.33%
2024NZ$37.42-1.17%
2023NZ$37.861%
2022NZ$37.49144.72%
2021NZ$15.32-133.49%
2020NZ-$45.73451.13%
2019NZ-$8.30266.17%
2018NZ-$2.27-105.85%
2017NZ$38.75166.28%
2016NZ$14.550.71%
2015NZ$14.4514.44%
2014NZ$12.63

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
Cerner
CERN
NZ$3.41-94.27%๐Ÿ‡บ๐Ÿ‡ธ USA
Henry Schein
HSIC
NZ$5.44-90.86%๐Ÿ‡บ๐Ÿ‡ธ USA
AmerisourceBergen
ABC
NZ$14.13-76.26%๐Ÿ‡บ๐Ÿ‡ธ USA
Cardinal Health
CAH
NZ$11.35-80.93%๐Ÿ‡บ๐Ÿ‡ธ USA
Premier
PINC
NZ-$0.46-100.77%๐Ÿ‡บ๐Ÿ‡ธ USA
Patterson Companies
PDCO
NZ$2.66-95.53%๐Ÿ‡บ๐Ÿ‡ธ USA
Computer Programs and Systems
CPSI
NZ-$5.37-109.02%๐Ÿ‡บ๐Ÿ‡ธ USA
Veradigm
MDRX
NZ$0.85-98.57%๐Ÿ‡บ๐Ÿ‡ธ USA
Owens & Minor
OMI
NZ-$29.65-149.84%๐Ÿ‡บ๐Ÿ‡ธ USA